Novelstar Pharmaceuticals Inc.
Lijia Yang is a Senior Scientist at Novelstar Pharmaceuticals Inc. since September 2021, specializing in the development, transfer, and validation of analytical methods for pharmaceutical dosage forms, utilizing a variety of analytical techniques including HPLC, UPLC, and mass spectrometry. Prior experience includes roles as Research Scientist and Facility Manager at The City College of New York, overseeing mass spectrometry facilities and conducting quantitative and qualitative analyses, as well as a Post-doctoral Research Associate position at Virginia Tech focused on cigarette smoke condensate analysis. Lijia Yang has a Ph.D. in Analytical Chemistry from The Graduate Center, City University of New York, and a B.S. in Chemistry from Fudan University.
This person is not in the org chart
This person is not in any teams
Novelstar Pharmaceuticals Inc.
Novelstar Pharmaceuticals Inc., founded in August, 2018, is a Company of Fosun Pharma focusing on the development of special pharmaceutical products of NDA and ANDA with advanced drug delivery systems. Our parent company, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. was founded in 1994 and is a leading health and medical industry group in China. Fosun Pharma has a mission to promote human health. Its business covers the whole pharmaceutical industry chain, including drug manufacturing and R & D, medical services, medical device and medical diagnostics, pharmaceutical distribution and retail. Fosun Pharma has a state-of-the-art innovative technology center and an international R & D team. It continuously focuses on innovative research and development in cardiovascular, central nervous system, blood system, metabolism and digestive system, anti-infective and anti-tumor therapeutic fields. Facing the future, Fosun Pharma will adhere to the brand philosophy of “continuing to innovate and enjoy health” and continue to adhere to the development strategy of “endogenous growth, outward expansion and integrated development”, and strive to become the first-class enterprise in the global mainstream medical and health market. Learn more on the FosunPharma website: https://www.fosunpharma.com/en/